Lower adalimumab trough levels are associated with higher bowel wall thickness in Crohn's disease

BACKGROUND: In Crohn's disease, higher adalimumab trough levels and negative anti-adalimumab-antibodies associate with better clinical and endoscopic outcomes. Intestinal ultrasound has become a relevant non-invasive method to monitor treatment. However, data on the association between adalimum...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:United European Gastroenterol J
Autores principales: Ungar, Bella, Ben-Shatach, Zohar, Selinger, Limor, Malik, Alona, Albshesh, Ahmad, Ben-Horin, Shomron, Eliakim, Rami, Kopylov, Uri, Carter, Dan
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7079273/
https://ncbi.nlm.nih.gov/pubmed/32213067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619878974
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares